A Multidisciplinary Approach to Reducing the Burden of Infectious Disease
The Vaccine and Infectious Disease Division (VIDD) is a recognized leader in translational and “bench-to-bedside” science. VIDD integrates the expertise and creativity of scientists in basic, translational and clinical research to prevent, treat and cure infectious diseases, including known and emerging infections of global health importance such as COVID-19, HIV and cancer-related infectious diseases.
VIDD’s research activities are conducted in collaboration with partners around the world and include laboratory, clinical and field-based work across multiple regions. The locations shown here are representative of VIDD’s global engagement and collaborations, which evolve over time as projects begin, conclude or transition.
Applying an innovative multidisciplinary approach, the division houses three formal research programs — Biostatistics, Bioinformatics and Epidemiology; Immunology and Vaccine Development; and Infectious Disease Sciences — which pursue coordinated strategies to reduce the burden of infectious disease.
VIDD also supports large international research networks that bring together investigators and institutions globally to advance the development of vaccines and other preventive and therapeutic interventions for infectious diseases.
Creating Better Outcomes
Our multidisciplinary faculty perform laboratory and clinical research as well as employ advanced computational methods to gain insight into how to better predict, prevent and treat infectious diseases.
A Global Approach
Division researchers study multiple infectious diseases, such as COVID-19, HIV, malaria and influenza. Our goal is to develop vaccines and therapies that reduce their impact.